NeuroPace Inc
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $100.0 | $79.9 | $65.4 | $45.5 | $45.2 |
| Operating income | -$16.3 | -$21.7 | -$27.2 | -$40.8 | -$23.7 |
| Net income | -$21.5 | -$27.1 | -$33.0 | -$47.1 | -$36.1 |
| Cash Flow Statement | |||||
| Free cash flow | -$11.3 | -$18.3 | -$19.9 | -$37.5 | -$25.0 |
| Share repurchases | $49.5 | $0.0 | — | $0.0 | — |
Shares outstanding 34.3M · Free float 58.1%
Annual filing data through FY ended December 31, 2025; float as of September 30, 2026.